ticagrelor 274693 27 5

Ticagrelor, a new platelet aggregation inhibitor, is the worlds first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist. It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome. Product Name: Ticagrelor CAS No.: 274693-27-5 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C23H28F2N6O4S Molecular Weight: 522.57 Shelf Life: 2 Years Package: 25kg/drum